His scientific interests lie mostly in Intensive care, Intensive care unit, Intensive care medicine, Sepsis and Prospective cohort study. His studies in Intensive care integrate themes in fields like Observational study, Nursing, Multivariate analysis, Pediatrics and Triage. His biological study spans a wide range of topics, including Psychological intervention, Incidence, Health care, Intervention and Risk factor.
The concepts of his Intensive care medicine study are interwoven with issues in MEDLINE and Anesthesiology. His Sepsis research focuses on Septic shock in particular. His work is dedicated to discovering how Septic shock, Hydrocortisone are connected with Adrenal insufficiency and other disciplines.
Charles L. Sprung spends much of his time researching Intensive care medicine, Intensive care, Intensive care unit, Internal medicine and Sepsis. Charles L. Sprung is interested in Critically ill, which is a branch of Intensive care medicine. His Intensive care research includes elements of MEDLINE, Nursing, Triage, Medical emergency and Anesthesiology.
His Intensive care unit research is multidisciplinary, relying on both Critical care nursing, Observational study, Family medicine, Emergency medicine and Prospective cohort study. His Sepsis study focuses on Septic shock in particular. As part of one scientific family, Charles L. Sprung deals mainly with the area of Septic shock, narrowing it down to issues related to the Anesthesia, and often Oncotic pressure.
Charles L. Sprung mostly deals with Intensive care, Intensive care unit, Intensive care medicine, Triage and MEDLINE. His Intensive care study also includes
His Intensive care medicine research includes themes of Septic shock and Sepsis. He has researched Septic shock in several fields, including Anesthesia and Cardiology. His study explores the link between MEDLINE and topics such as Family medicine that cross with problems in Published Erratum.
Intensive care, Intensive care unit, Intensive care medicine, Triage and Medical emergency are his primary areas of study. The various areas that Charles L. Sprung examines in his Intensive care study include Critical care nursing, Multidisciplinary approach and Nursing, Palliative care, End-of-life care. His Intensive care unit research is multidisciplinary, incorporating elements of Observational study and Emergency medicine.
His Intensive care medicine study integrates concerns from other disciplines, such as Surviving Sepsis Campaign, Early goal-directed therapy and Septic shock, Sepsis. His Early goal-directed therapy study combines topics in areas such as Sepsis mortality, Sepsis Six, Lactate clearance and Pediatric sepsis. His work deals with themes such as Icu admission, MEDLINE and Anesthesiology, which intersect with Medical emergency.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
Dellinger Rp;Levy Mm;Rhodes A;Annane D.
Critical Care Medicine (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R. Phillip Dellinger;Mitchell M. Levy;Andrew Rhodes;Djillali Annane.
Intensive Care Medicine (2013)
Multiple organ dysfunction score : a reliable descriptor of a complex clinical outcome
John C. Marshall;Deborah J. Cook;Nicolas V. Christou;Gordon R. Bernard.
Critical Care Medicine (1995)
Sepsis in European intensive care units: results of the SOAP study.
Jean-Louis Vincent;Yasser Sakr;Charles L. Sprung;V Marco Ranieri.
Critical Care Medicine (2006)
Hydrocortisone Therapy for Patients with Septic Shock
Charles L. Sprung;Djillali Annane;Didier Keh;Rui Moreno.
The New England Journal of Medicine (2008)
End-of-life practices in European intensive care units: the Ethicus Study.
Charles L. Sprung;Simon L. Cohen;Peter Sjokvist;Mario Baras.
Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial
Charles J. Fisher;Jean-Francois A. Dhainaut;Steven M. Opal;John P. Pribble.
High-Dose Corticosteroids in Patients with the Adult Respiratory Distress Syndrome
Bernard Gr;Luce Jm;Sprung Cl;Rinaldo Je.
The New England Journal of Medicine (1987)
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.
Edward Abraham;Konrad Reinhart;Steven Opal;Ignace Demeyer.
A look into the nature and causes of human errors in the intensive care unit
Y Donchin;D Gopher;M Olin;Y Badihi.
Critical Care Medicine (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: